Andrew Witty

Sir Andrew Witty is a British business executive who has led two of the most significant companies in global healthcare, the pharmaceutical group GSK and the American health and insurance giant UnitedHealth Group. Born in 1964, Witty served as chief executive of GSK from 2008 to 2017 and then as chief executive of UnitedHealth Group from 2021 to 2025. Knighted for services to the economy and to the United Kingdom, he is one of the most experienced healthcare leaders of his generation, and his second tenure at UnitedHealth placed him at the center of one of the most turbulent periods in the American health industry.

This profile covers who Andrew Witty is, his early life and education, his long career at GSK, his leadership of UnitedHealth Group, his net worth, and where he stands today.

Early Life and Education

Andrew Philip Witty was born in 1964 in the United Kingdom. He studied at the University of Nottingham, where he earned a degree in economics. His connection to Nottingham would remain strong throughout his life, and he later served as chancellor of the university for several years, reflecting a lasting commitment to the institution and to British higher education.

Witty's background in economics, rather than science or medicine, shaped a career focused on the business and strategy of healthcare, on questions of pricing, access, organization and scale, rather than on laboratory research itself.

Career at GSK

Andrew Witty spent much of his career at GlaxoSmithKline, later known as GSK, joining the company early and rising through a series of international roles across Europe, Asia and the Americas. In 2008 he became chief executive of GSK, one of the largest pharmaceutical companies in the world.

As chief executive, Witty became known for positions that were sometimes unusual for a major drug company leader. He pushed for greater access to medicines in the developing world, supported lower pricing for the poorest countries and championed transparency in clinical trial data. He also reshaped the company through deals and restructuring across its pharmaceutical, vaccine and consumer health businesses. He was knighted in 2012, becoming Sir Andrew Witty, in recognition of his contributions. He stepped down from GSK in 2017 after nearly a decade at the helm.

Leading Optum and UnitedHealth Group

After GSK, Witty moved into the American healthcare system, joining UnitedHealth Group, the parent of the insurer UnitedHealthcare and the health services arm Optum. He led Optum and also took a leave to help the World Health Organization work on access to a COVID-19 vaccine during the pandemic, underlining his standing in global health.

In February 2021, Witty became chief executive of UnitedHealth Group as a whole, taking responsibility for the largest healthcare company in the United States by revenue, a business that touches a vast share of American health insurance and care delivery. He led the company through continued growth in both its insurance and its Optum services divisions.

A Turbulent Final Chapter

Witty's tenure at the top of UnitedHealth Group ended amid extraordinary pressure. In late 2024, the head of the UnitedHealthcare insurance unit was killed in a shocking crime that drew global attention and ignited public debate about the American health insurance industry. The company also faced intense scrutiny over costs, claims practices and its sheer scale.

In May 2025, Andrew Witty stepped down as chief executive of UnitedHealth Group. His departure marked the end of a leadership run that had spanned both triumph and crisis, and it placed him among the executives who have led at the very center of healthcare during one of its most contested moments.

Andrew Witty Net Worth

Andrew Witty net worth is not publicly disclosed in a precise figure. Unlike a founder whose wealth is tied to owning a company, Witty's wealth comes from decades of senior executive compensation at GSK and UnitedHealth Group. Chief executive pay at companies of that size runs into the tens of millions of dollars per year, weighted heavily toward stock and long term incentives.

Any specific number circulating online should be treated as an estimate. What is clear is that his wealth reflects a long and senior corporate career rather than a single founding event.

Personal Life and Public Profile

Andrew Witty is generally private about his personal life, with his public identity defined by his corporate and global health roles. He has maintained close ties to the United Kingdom, including his long association with the University of Nottingham, while spending much of his later career based in the United States. He is regularly cited as one of the most influential figures in global healthcare and has spoken widely on the future of medicine, health systems and access to care.

Achievements and Recognition

Andrew Witty's achievements include leading GSK through nearly a decade of change, advocating for wider access to medicines, supporting the global vaccine effort during the pandemic, and running the largest healthcare company in the United States. His knighthood and his selection for senior international health roles reflect a reputation that extends well beyond any single company.

Andrew Witty in 2026

As of 2026, having stepped down from UnitedHealth Group in 2025, Andrew Witty is one of the most experienced healthcare leaders available, and his next moves are closely watched across the industry. His career remains a reference point in debates about drug pricing, the structure of American healthcare and the responsibilities of the companies that dominate it.

He is profiled alongside other leaders in the Health sector on Founder Canon, the executives shaping how the world pays for and delivers care.